Prostate-specific antigen adjusted for the transition zone volume as a second screening test: A prospective study of 248 cases-Reference-Cited by-同舟云学术

Prostate-specific antigen adjusted for the transition zone volume as a second screening test: A prospective study of 248 cases

Published:2006-07 Issue:7 Volume:13 Page:910-914
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:

Author:

KANG SEOK-HO,BAE JAE-HYUN,PARK HONG-SEOK,YOON DUCK-KI,MOON DU-GEON,KIM JE-JONG,CHEON JUN

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1442-2042.2006.01439.x/fullpdf

Reference14 articles.

1. Relative sensitivity and specificity of serum prostate specific antigen (PSA) level compared with age-referenced PSA, PSA density and PSA change;Mettlin;Cancer,1994

2. A complex between prostate-specific antigen and alpha-1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer;Stenman;Cancer Res.,1991

3. Serum PSA adjusted for Volume of transition zone (PSATZ) is more accurate than PSA adjusted for total gland Volume (PSAD) in detecting adenocarcinoma of the prostate;Kalish;Urology,1994

4. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen;Benson;J. Urol.,1992

5. The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia;Weber;J. Urol.,1989

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of quantitative MRI-based prostate zonal parameters in predicting clinically significant prostate cancer;Canadian Urological Association Journal;2023-04-11

The Value of Prostate-Specific Antigen-Related Indexes and Imaging Screening in the Diagnosis of Prostate Cancer

;Cancer Management and Research;2020-08

3. Impact of PSA density of transition zone as a potential parameter in reducing the number of unnecessary prostate biopsies in patients with PSA levels between 2.6 and 10.0 ng/mL;International braz j urol;2018-08

4. Management of an Elevated PSA and Biopsy Strategies in the Large Prostate;The Big Prostate;2017-08-25

5. Prostate transitional zone volume-based nomogram for predicting prostate cancer and high progression prostate cancer in a real-world population;Journal of Cancer Research and Clinical Oncology;2017-03-10